RxDoctor Payments Data

Bryan Barnes, DO

Family Medicine · Joplin, MONPI 1720015613

Payments from drug & device makers

$315in general payments, 2019–2025

Across 24 payments — averaging $13.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$125
  • Novo Nordisk$52
  • Takeda Pharmaceuticals U.S.A., Inc.$33
  • Johnson & Johnson$32
  • Boehringer Ingelheim$30
  • Amgen$16
  • plus $27 from 2 others

What the payments were for

  • Food & beverage$315100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$315 in reported general payments places this provider in the 45th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$229,330
Medicare patients
329
Services billed
4,557

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide148$162,518
OzempicSemaglutide93$93,209
EliquisApixaban74$58,492
JardianceEmpagliflozin53$47,341
TrulicityDulaglutide32$42,939
XareltoRivaroxaban53$40,110
JanumetSitagliptin Phos/Metformin Hcl52$39,695
TradjentaLinagliptin45$37,487
JanuviaSitagliptin Phosphate32$27,089
FarxigaDapagliflozin Propanediol21$22,640
Janumet XrSitagliptin Phos/Metformin Hcl16$19,708
LinzessLinaclotide35$18,813
SymbicortBudesonide/Formoterol Fumarate48$16,642
Breo ElliptaFluticasone/Vilanterol26$15,348
MyrbetriqMirabegron30$14,356

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$52$93,20993 claims
Boehringer IngelheimJardiance, Tradjenta$30$84,82798 claims
PfizerEliquis$125$58,49274 claims
Johnson & JohnsonXarelto$32$40,11053 claims
AstraZenecaFarxiga, Symbicort$15$39,28369 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Joplin

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →